• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Carotid Long Lesions: Think Outside the Box

  • Wed, 10/12/11 - 11:32am
  • 1010 reads
  • 0 comments

Authors: Richard R. Heuser, MD, FACC, FACP, FESC, FSCAI, Hursh Naik, MD, Mark Boulware, MD

A 69-year-old male patient presented with asymptomatic carotid artery stenosis. The patient is considered high-risk because of non-revascularizable coronary disease and bilateral carotid disease. He had undergone previous left carotid endarterectomy and had a new right internal carotid artery stenosis by both carotid Doppler and CTA of 90%. The patient was enrolled in the Abbott CHOICE high-risk protocol. The patient had the procedure done via the right groin with a VTK catheter (Cook Medical, Bloomington, Indiana) placed through a 6 Fr shuttle (Cook Medical). The Emboshield (Abbott, Abbott Park, Illinois) was passed and the lesion was predilated with a Viatrak 4.0 balloon (Abbott). After predilation, the Exact 40 mm stent (Abbott) could not be passed. We went in with a Viatrak 5.0 balloon and inflated several times, but still could not pass the stent. Following this, we used a 3.5 x 20 mm AngioScope balloon (AngioScore, Fremont, California), which clearly showed the indentation with inflation and resolved. Following this, the 8/6 40mm Exact stent was passed easily. With deployment of the stent, we post-dilated with the Viatrak 5.0 balloon and the stent appeared to be fully deployed. We performed an angiogram with the filter still in place, which revealed delayed filling. Because of this, we passed a Pronto catheter (Vascular Solutions, Minneapolis, Minnesota) and performed multiple suctions. In spite of multiple aspirations, even after 4 suctions, there was still embolic material present (Figure 1). However, the thrombotic material finally cleared after 6 aspirations and an angiogram confirmed that the TIMI delayed filling had resolved and the filter was removed with excellent angiographic result.

This case showed 2 problems. The length of the lesion made it clear that adequate predilation was necessary. In this case with the non-approved application of the AngioScope balloon to predilate, it was possible for us to place the stent. Secondly, a delayed filling after filter placement showed the necessity of suction after deployment of the stent in this case was vital. The amount of material suggested that this was a lesion with a large thromboembolic load.

Figure 1. Carotid angiogram prior to intervention.

 

 

 

Figure 2. Carotid angiogram following placement of the stent revealing delayed filling.

 

 

 

Figure 3. Carotid angiogram revealing carotid delayed filling.

 

 

 

Figure 4. Final angiographic result.

 

 

 

Figure 5. The filter aspiration revealed extensive thromboembolic material.

image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Tara Fields, Classified Sales Manager
    (800) 237-7285, ext. 259

vdm Blogs

EVAR found superior to Open AAA Repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

Frank J Criado MD FACS FSVM

Aneurysms and Cancer: Which comes first in the endovascular era?

Ross Milner MD FACS

What is the best therapy when we compare current data for revascularization of the SFA?

Lawrence A. Garcia MD

When a Patient Presents with an Ulcer, Take a Careful History

Richard R. Heuser MD FACC FACP FESC FSCAI

Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies?

Frank J Criado MD FACS FSVM
more »

Vascular Newswire

  • Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe
    Thu, 05/17/12 - 10:22am
  • Abbott's XIENCE PRIME and XIENCE V Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy
    Wed, 05/16/12 - 9:26am
  • Hospital Mortality Rates for Cardiovascular Revascularization Patients Varies Significantly by State
    Tue, 05/15/12 - 9:31am
  • Boston Scientific Announces CE Mark and European Launch of Innova Self-expanding Bare-metal Stent System
    Mon, 05/14/12 - 12:07pm
more »

Clinical Events Calendar

  • EuroPCR 2012
    Tue, 05/15/2012 - Fri, 05/18/2012
    Paris, France
  • International Vein Congress (IVC) 2012
    Thu, 05/31/2012 - Sun, 06/03/2012
    Miami Beach, FL, United States
  • New Cardiovascular Horizons (NCVH)
    Wed, 06/06/2012 - Sat, 06/09/2012
    New Orleans, LA, United States
more »

Poll

The current focus to decrease the profile size of aortic stent-grafts: :
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications